Center-involved diabetic macular edema

Clinical trials for Center-involved diabetic macular edema explained in plain language.

Never miss a new study

Get alerted when new Center-involved diabetic macular edema trials appear

Sign up with your email to follow new studies for Center-involved diabetic macular edema, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 2 Not yet finished but already full! 1 Completed 1

Can a One-Time gene therapy offer lasting protection for diabetic retinopathy?

Disease control By invitation only

This study is a long-term follow-up for people who previously received an injection of RGX-314, a gene therapy, for diabetic retinopathy (with or without diabetic macular edema). The purpose is to monitor the safety and effectiveness of the treatment over a total of five years af…

Matched conditions: CENTER-INVOLVED DIABETIC MACULAR EDEMA

Phase 2 • Sponsor: AbbVie • Aim: Disease control

Last updated Aug 07, 2026 00:00 UTC

Center-involved diabetic macular edema

Get alerted when new Center-involved diabetic macular edema trials appear

Can a One-Time gene therapy offer lasting protection for diabetic retinopathy?